| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |